<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Cushing VI</submitter><funding>Cancer Research UK</funding><funding>Medical Research Council</funding><pagination>2265</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10937634</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>15(1)</volume><pubmed_abstract>Rational design of next-generation therapeutics can be facilitated by high-resolution structures of drug targets bound to small-molecule inhibitors. However, application of structure-based methods to macromolecules refractory to crystallization has been hampered by the often-limiting resolution and throughput of cryogenic electron microscopy (cryo-EM). Here, we use high-resolution cryo-EM to determine structures of the CDK-activating kinase, a master regulator of cell growth and division, in its free and nucleotide-bound states and in complex with 15 inhibitors at up to 1.8 Å resolution. Our structures provide detailed insight into inhibitor interactions and networks of water molecules in the active site of cyclin-dependent kinase 7 and provide insights into the mechanisms contributing to inhibitor selectivity, thereby providing the basis for rational design of next-generation therapeutics. These results establish a methodological framework for the use of high-resolution cryo-EM in structure-based drug design.</pubmed_abstract><journal>Nature communications</journal><pubmed_title>High-resolution cryo-EM of the human CDK-activating kinase for structure-based drug design.</pubmed_title><pmcid>PMC10937634</pmcid><funding_grant_id>C37/A12011</funding_grant_id><funding_grant_id>C37/A9335</funding_grant_id><funding_grant_id>C37/A18784</funding_grant_id><funding_grant_id>MR/V009354/1</funding_grant_id><pubmed_authors>Cushing VI</pubmed_authors><pubmed_authors>Koh AF</pubmed_authors><pubmed_authors>Kroll SHB</pubmed_authors><pubmed_authors>Jurgaityte K</pubmed_authors><pubmed_authors>Greber BJ</pubmed_authors><pubmed_authors>Bahl AK</pubmed_authors><pubmed_authors>Barrett AGM</pubmed_authors><pubmed_authors>Feng J</pubmed_authors><pubmed_authors>Bondke A</pubmed_authors><pubmed_authors>Ali S</pubmed_authors><pubmed_authors>Kotecha A</pubmed_authors><pubmed_authors>Barbazanges M</pubmed_authors><pubmed_authors>Scheiper B</pubmed_authors></additional><is_claimable>false</is_claimable><name>High-resolution cryo-EM of the human CDK-activating kinase for structure-based drug design.</name><description>Rational design of next-generation therapeutics can be facilitated by high-resolution structures of drug targets bound to small-molecule inhibitors. However, application of structure-based methods to macromolecules refractory to crystallization has been hampered by the often-limiting resolution and throughput of cryogenic electron microscopy (cryo-EM). Here, we use high-resolution cryo-EM to determine structures of the CDK-activating kinase, a master regulator of cell growth and division, in its free and nucleotide-bound states and in complex with 15 inhibitors at up to 1.8 Å resolution. Our structures provide detailed insight into inhibitor interactions and networks of water molecules in the active site of cyclin-dependent kinase 7 and provide insights into the mechanisms contributing to inhibitor selectivity, thereby providing the basis for rational design of next-generation therapeutics. These results establish a methodological framework for the use of high-resolution cryo-EM in structure-based drug design.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Mar</publication><modification>2026-07-15T13:55:37.719Z</modification><creation>2026-07-05T03:12:06.741Z</creation></dates><accession>S-EPMC10937634</accession><cross_references><pubmed>38480681</pubmed><doi>10.1038/s41467-024-46375-9</doi></cross_references></HashMap>